A Prospective Feasibility Trial to Challenge Patient–Derived Pancreatic Cancer Organoids in Predicting Treatment Response
Real-time isolation, propagation, and pharmacotyping of patient-derived pancreatic cancer organoids (PDOs) may enable treatment response prediction and personalization of pancreatic cancer (PC) therapy. In our methodology, PDOs are isolated from 54 patients with suspected or confirmed PC in the fram...
Main Authors: | Alica K. Beutel, Lena Schütte, Jeanette Scheible, Elodie Roger, Martin Müller, Lukas Perkhofer, Annika M. T. U. Kestler, Johann M. Kraus, Hans A. Kestler, Thomas F. E. Barth, Johannes Lemke, Marko Kornmann, Thomas J. Ettrich, Johann Gout, Thomas Seufferlein, Alexander Kleger |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-05-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/13/11/2539 |
Similar Items
-
Pancreatic Ductal Organoids React Kras Dependent to the Removal of Tumor Suppressive Roadblocks
by: Lukas Perkhofer, et al.
Published: (2019-01-01) -
Organoids and Colorectal Cancer
by: Antonio Barbáchano, et al.
Published: (2021-05-01) -
Human Blood Vessel Organoids Penetrate Human Cerebral Organoids and Form a Vessel-Like System
by: Yujin Ahn, et al.
Published: (2021-08-01) -
Organoids to model the endometrium: implantation and beyond
by: Thomas M Rawlings, et al.
Published: (2021-09-01) -
Integration of Sensors in Gastrointestinal Organoid Culture for Biological Analysis
by: Ge-Ah Kim, et al.
Published: (2018-01-01)